Short answer
Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Website designated as a distribution channel for material company information.
Aveanna Healthcare Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Website designated as a distribution channel for material company information
- Investors directed to Aveanna’s “Investors” section for time-critical disclosures
- Website information not incorporated into this Form 8-K or filing record
Item EX-99.1 · Exhibit EX-99.1
- Q2 2026 revenue $670.5m, up 13.7%; Adjusted EBITDA $95.4m, up 8.0%
- Positive free cash flow $75.4m, improving $38.5m versus 2025; operating cash flow $85.3m
- 2026 guidance: revenue above $2.68b and Adjusted EBITDA above $365m
- Liquidity $432.7m against $1.483b variable-rate debt, leaving refinancing and interest-rate sensitivity
- Growth strategy targets 5–7% organic growth, 3–4% M&A growth, and 8–11% long-term growth rate
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aveanna Healthcare Holdings, Inc. 8-K filings
Get the next AVAH 8-K as it lands
Follow AVAH for push alerts, or ask the research agent what this filing means.